131 related articles for article (PubMed ID: 8112468)
1. 'Camelising' human antibody fragments: NMR studies on VH domains.
Davies J; Riechmann L
FEBS Lett; 1994 Feb; 339(3):285-90. PubMed ID: 8112468
[TBL] [Abstract][Full Text] [Related]
2. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.
Muyldermans S; Atarhouch T; Saldanha J; Barbosa JA; Hamers R
Protein Eng; 1994 Sep; 7(9):1129-35. PubMed ID: 7831284
[TBL] [Abstract][Full Text] [Related]
3. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
Riechmann L
J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
[TBL] [Abstract][Full Text] [Related]
4. Single domain antibodies: comparison of camel VH and camelised human VH domains.
Riechmann L; Muyldermans S
J Immunol Methods; 1999 Dec; 231(1-2):25-38. PubMed ID: 10648925
[TBL] [Abstract][Full Text] [Related]
5. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
Davies J; Riechmann L
Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring antibodies devoid of light chains.
Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme.
Desmyter A; Transue TR; Ghahroudi MA; Thi MH; Poortmans F; Hamers R; Muyldermans S; Wyns L
Nat Struct Biol; 1996 Sep; 3(9):803-11. PubMed ID: 8784355
[TBL] [Abstract][Full Text] [Related]
8. Backbone assignment, secondary structure and protein A binding of an isolated, human antibody VH domain.
Riechmann L; Davies J
J Biomol NMR; 1995 Sep; 6(2):141-52. PubMed ID: 8589603
[TBL] [Abstract][Full Text] [Related]
9. The specific variable domain of camel heavy-chain antibodies is encoded in the germline.
Nguyen VK; Muyldermans S; Hamers R
J Mol Biol; 1998 Jan; 275(3):413-8. PubMed ID: 9466919
[TBL] [Abstract][Full Text] [Related]
10. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
Rouet R; Dudgeon K; Christie M; Langley D; Christ D
J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant design and expression of human three-domain antibody against BoNTa].
Wang H; Yin J; Shi J; Meng LL; Li PZ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):223-5. PubMed ID: 15989265
[TBL] [Abstract][Full Text] [Related]
12. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
13. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
[TBL] [Abstract][Full Text] [Related]
14. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface.
Vranken W; Tolkatchev D; Xu P; Tanha J; Chen Z; Narang S; Ni F
Biochemistry; 2002 Jul; 41(27):8570-9. PubMed ID: 12093273
[TBL] [Abstract][Full Text] [Related]
16. Single domain camel antibodies: current status.
Muyldermans S
J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
[TBL] [Abstract][Full Text] [Related]
17. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K
J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608
[TBL] [Abstract][Full Text] [Related]
18. Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41.
Kortt AA; Guthrie RE; Hinds MG; Power BE; Ivancic N; Caldwell JB; Gruen LC; Norton RS; Hudson PJ
J Protein Chem; 1995 Apr; 14(3):167-78. PubMed ID: 7576085
[TBL] [Abstract][Full Text] [Related]
19. [Progress in single-domain antibody derived from heavy-chain antibody].
Cui HQ; Wang QM
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):497-501. PubMed ID: 16108383
[TBL] [Abstract][Full Text] [Related]
20. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
Saini SS; Farrugia W; Ramsland PA; Kaushik AK
Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
